Meetings - ISHLT Academy > Academy Scientific Program





2012:  CORE COMPETENCIES IN MECHANICAL CIRCULATORY SUPPORT
Tuesday, April 17, 2012   Prague Congress Center

2012 ISHLT Academy Preliminary Program (PDF)

SCHEDULE

SESSIONTIMETITLE - GOAL OF TALKSPEAKERCOUNTRY
Introduction7:30-7:45 AMWelcome and Brief OverviewJeff Teuteberg, University of PittsburghUSA
Section 1 - Review of the Current State of MCS
 7:45-8:00 AMTechnology 101: Review of current technologies, types of flow, pump parametersFrank Pagani, University of MichiganUSA
 8:00-8:15 AMBTT/Long-Term Support/Recovery: review state of outcomes and adverse events with current technologiesAndreas Zuckermann, University of ViennaAustria
 8:15-8:30 AMShock - role of biventricular support, TAH and ECMOAlain Pavie, La PitieFrance
 8:30-8:45 AMQ & A  
Section 2 - Patient Selection
 8:45-9:00 AMWorrisome Signals - risk factors which presage patient decline: renal function, intolerance of medications, hospitalizations, etc.Nicholas Banner, Harefield HospitalUnited Kingdom
 9:00-9:15 AMRisk Prediction Models - review of risk prediction, what they can and can't tell us: MV02, SHFM, etc.Keith Aaronson, University of MichiganUSA
 9:15-9:30 AMTiming of Implantation - when is the patient "sick enough" to implant MCS; case studiesAndrew Boyle, Aurora St. Luke'sUSA
 9:30-9:45 AMQ & A  
Break9:45-10:00 AM   
Section 3 - Medical Considerations
 10:00-10:15 AMRV Assessment and Prediction - brief overview of impact of RV failure, pre-operative assessment and management of the RV, risk prediction; case examplesDavid Feldman, Abbott NorthwesternUSA
 10:15-10:30 AMEnd-organ Assessment - review of organ recoverability: renal, hepatic, vascular, overall medical candidacyLee Goldberg, University of PennsylvaniaUSA
 10:30-10:45 AMInfection: ISHLT Consensus Definitions - overview of the ISHLT consensus guideline definitions of infectionsMargaret Hannan, Mater HospitalIreland
 10:45-11:00 AMQ & A  
Section 4 - Surgical Considerations
 11:00-11:15 AMImplantation 101 - overview of the most crucial surgical considerations: inflow cannual/pump placement, driveline, etc.Nader Moazami, Abbott NorthwesternUSA
 11:15-11:30 AMHow Much Else is Too Much? - concomitant operative procedures: TV, Aortic valve, prior Dor, congenitalsRoland Hetzer, Berlin Heart InstituteGermany
 11:30-11:45 AMMatching Pumps to Patients - considerations for device type, type of flow based upon patient factorsMark Slaughter, University of LouisvilleUSA
 11:45-12:00 PMQ & A  
Lunch12:00-1:15 PMMeant to give enough time for the participants and speakers to interact.  Speakers will be encouraged, particularly those that just spoke or are just about to speak, to sit with participants.  
Section 5 - Pediatric Considerations
 1:15-1:30 PMPediatric Perspective - on current state of technology, patient/device selection, medical/surgical considerationsDavid Morales, Texas Children's HospitalUSA
Section 6 - Post-op
 1:30-1:45 PMPost-op Pearls in the ICU - managing the patient in the immediate post-operative periodAngela Rajek, University of ViennaAustria
 1:45-2:00 PMManaging the RV - post-operative approach to the RV: surgical considerations, pump speed, iNO, inotropes, etcMartin Strueber, Hannover Medical SchoolGermany
 2:00-2:15 PMAnticoagulation - overview of the timing and type of anticoagulation, means to monitor state of anticoagulation, anticoagulation management for elective proceduresVivek Rao, University of TorontoCanada
 2:15-2:30 PMQ & A  
Section 7 - Transition ot Home
 2:30-2:45 PMTeaching/Patient Assessment - outline of approach to teaching patient and their family and communityMichael Petty, University of MinnesotaUSA
 2:45-3:00 PMKeeping Patients at Home - community support, restrictions, role of local providersKarl Nelson, Intermountain HealthUSA
 3:00-3:15 PMQuality of Life and Functional Capacity - the need for, timing of and measures to assessKathy Grady, Northwestern UniversityUSA
 3:15-3:30 PMQ & A  
Break3:30-3:45 PM   
Section 8 - Long-Term Management
 3:45-4:00 PMGI Bleeding - review of pathophysiology, incidence, and diagnostic/therapeutic approachDaniel Goldstein, Montefiore Medical CenterUSA
 4:00-4:15 PMDriveline Infections - definition (ISHLT consensus statement), prevention, treatmentEvgenij Potapov, Berlin Heart InstituteGermany
 4:15-4:30 PMOutpatient Management - clinic structure, typical items addressed, focused medical management (BP, rhythms, etc), rehabJoseph Rogers, Duke University Medical CenterUSA
 4:30-4:45 PMRole of Imaging - Echo (basic views, how to assess functionality, set speed, how often, case presentations); CT (when it is useful, what can really be assessed, case presentations)Shashank Desai, Inova FairfaxUSA
 4:45-5:00 PMEnd of Life Considerations - cause of death on MCS, establishing goals, end-of-life careSalpy Pamboukian, University of Alabama-BirminghamUSA
 5:00-5:15 PMQ & A  
Section 9 - Trouble Shooting -- Case Presentations
 5:15-5:25 PMRV FunctionMichele Pilato, ISMETT, PalermoItaly
 5:25-5:35 PMDrivelineChris Salerno, St. VincentUSA
 5:35-5:45 PMHemolysis/BleedingSean Pinney, Mt. SinaiUSA
 5:45-5:55 PMThrombusGeorge Wieselthaler, University of California-San FranciscoUSA
Review
 6:00-6:15 PMISHLT MCS GuidelinesJeffrey Teuteberg, University of Pittsburgh
Andreas Zuckermann, University of Vienna
David Feldman, Abbot Northwestern		USA
Austria
USA
Summary/Adjourn6:15   
Reception  --  6:15-7:45 PM
Text SizeIncrease Font SizeDecrease Font Size